Telehealth is a tool, not a trial design. Learn how televisits, ePRO, and remote monitoring fit into traditional, hybrid, and decentralized clinical trials.
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- How To Operationalize AI-Enabled eTMF Systems Under The EU AI Act (Part 2)
- How AI-Enabled eTMF Systems Are Impacted By The EU AI Act (Part 1)
- Making AI Safety Routine: How Sites And Sponsors Can Continuously Monitor Clinical AI
- How Can AI Change Computerized System Validation?
- Digital Tools Are Failing Patients: 3 Ways Clinical Supply Can Protect Data Integrity
ON-DEMAND WEBINARS
This presentation explores how digital health tools and AI diagnostics are transforming clinical research, driving accurate evaluations and faster therapy development for chronic pain and neurological disorders.
CGT pioneers require supply chain partnerships that mitigate trial risk and complexity. Explore how to optimize pre-trial and pre-screening activities and reduce trial cost and risk with an IRT solution.
GSK leveraged an agile approach and modern ways of working to help shorten their EDC build times. Learn how they reduced EDC build and UAT times by 50% and had all new studies built within Vault CDMS in 18 months.
In a recent webinar, Sanofi and Flatiron Health leaders shared how a large academic medical center saved time and effort on trial data management using Flatiron Clinical Pipe™.
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![eSource Is Here: What To Do Today To Ensure Success Tomorrow]( "Enabling Regulatory Support For eSource")
Enabling Regulatory Support For eSourceDelve into an illustration of how robust EDC systems fully support the operational requirements introduced by the decision to leverage eSource data.
-
![GettyImages-1390654899 esource patient]( "How Capturing Data Directly Is Transforming Trials")
How Capturing Data Directly Is Transforming TrialsWith the right eSource technology, discover how trial data can be aggregated, integrated, and classified to accelerate data analysis for insight-based decisions in real time.
-
![eConsent-Informed-tablet-iPad]( "Minimizing Hurdles For Patients During The eConsent Process")
Minimizing Hurdles For Patients During The eConsent ProcessLearn how eConsent digitalizes the trial participant consent process through increasingly simplified models designed to improve comprehension and boost engagement.
-
![Guidance GettyImages-1402321498]( "5 Key Takeaways From The FDA's Real-World Evidence Guidance")
5 Key Takeaways From The FDA's Real-World Evidence GuidanceWith our advanced technology and expertise, sponsors can confidently conduct RWE studies that are efficient and aligned with the FDA’s data-driven vision for healthcare.
-
![Komodo Health - One Day Summit 2023]( "One Day, Clinical Trials Will Represent The Real World")
One Day, Clinical Trials Will Represent The Real WorldWhat needs to happen for RWE to reach its full regulatory potential? We discussed this with industry leaders during the One Day Summit, and here are some key takeaways.
-
![GettyImages-1315159023 oncology ps]( "Addressing The Specific Complexities Of Oncology eCOA Clinical Trials")
Addressing The Specific Complexities Of Oncology eCOA Clinical TrialsWhat are the specific tools and keys to conduct eCOA trials in oncology successfully? This article identifies some of the relevant solutions to tackle oncology protocol complexities.
-
![GettyImages-1197955157-finances-money-financial-valuation]( "Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study")
Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 StudyExplore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.
-
![How Should Biosimilar Companies Approach Real-World Evidence?]( "Evidence Generation Evolved")
Evidence Generation EvolvedExplore how innovative strategies are cutting clinical trial times in half and accelerating the delivery of life-saving treatments.
-
![GettyImages-2184303900- medica-2025-edc]( "The New Standard In Participant-Centric Trials")
The New Standard In Participant-Centric TrialsClinical technology must serve both scientific rigor and human experience—and Castor is positioning itself at the forefront of this participant-led future.
-
![GettyImages-966826582 data, research, analytics]( "8 Key Applications Of Real-World Data In Multiple Myeloma Therapy Development")
8 Key Applications Of Real-World Data In Multiple Myeloma Therapy DevelopmentExplore how therapeutic area (TA) datasets can be leveraged to address the challenges multiple myeloma (MM) presents in the field of hematologic malignancies.
FROM THE EDITOR
- Telehealth In Clinical Trials: What You Need To Know
- Forget More Clinical Tech, We Need More Adoption
- Joe Dustin: Sites Are Driving Clinical Tech Evolution
- How Salk And Sabin Helped Create The Modern Clinical Trial
- Why HEOR Keeps Arriving Too Late — And How ClinOps Can Fix It
- FDA Vs. MHRA Vs. EMA: Differences In Externally Controlled Trials
- RWE Is Growing Up, And Here's Why That Matters
FEATURED PRODUCTS & SERVICES
RECENT NEWSLETTERS
- 02.26.26 -- EU AI Act Compliance For eTMF Systems: What Clinical Tech Leaders Need To Know
- 02.19.26 -- The Clinical Tools Quietly Reshaping Trial Operations
- 02.12.26 -- How Can AI Change Computerized System Validation?
- 02.05.26 -- Digital Tools Are Failing Patients: Three Ways Clinical Supply Protects Data
- 01.29.26 -- Digital Protocols Are At An Inflection Point: A Conversation With Novartis And TransCelerate Leaders